DPS Group’s Tom Struble Named to Board of Directors of ISPE Boston Chapter

10/22/18

Tom Struble (Photo credit: Andy Ryan Photography)

DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, announced today that CQV Senior Project Manager Tom Struble has been selected as a new Board of Directors member of the Boston chapter of the International Society of Pharmaceutical Engineering (ISPE). An active member since 2011, he has served mostly with the Product Show Planning Committee, working in many capacities focusing on education and event exhibitors, culminating in chairing the committee the past two years.

A former Submarine Officer in the U.S. Navy, Tom has over 15 years of experience managing projects, with eight of those in the pharmaceutical and biotech industry. He is a graduate of Cornell University and earned a master’s degree in engineering management from Old Dominion University.

Founded in 1992, the ISPE Boston Area Chapter is the largest and most active chapter of the ISPE, an international organization whose mission is to deliver technical and operational solutions to support pharmaceutical and bio-pharmaceutical professionals across the globe. The Boston Area Chapter now provides educational, career development and networking opportunities to over 1,700 technical professionals across New England.

About DPS Group

DPS Group is a global engineering, consulting and project management company, serving high-tech industries around the world. DPS delivers services for clients across the complete engineering and construction value chain including feasibility studies, concepts, consulting, architecture, engineering, procurement, construction management, commissioning, qualification and validation; as well as contingent staffing solutions.

DPS applies its extensive Process Engineering expertise built over 44 years, as well as significant Lean Construction experience to assist our clients in high-end process sectors such as pharmaceuticals, biotech and semiconductors deliver their manufacturing facilities speedily, safely and cost effectively. What sets us apart are the partnerships we build with our clients through a fundamental understanding of their businesses and our own agility, flexibility, original thinking and our high-caliber people.

We have grown substantially in recent years and now employ over 1,400 people in our offices and on client sites in Ireland, UK, Netherlands, Belgium, Sweden, Switzerland, Israel, Singapore and the United States. For more information, visit www.dpsgroupglobal.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.